Week 96 analysis of rilpivirine or efavirenz in HIV-1-infected patients with baseline viral load ≤ 100 000 copies/mL in the pooled ECHO and THRIVE phase 3, randomized, double-blind trials (Q42249739)
Jump to navigation
Jump to search
scientific article published on 28 August 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Week 96 analysis of rilpivirine or efavirenz in HIV-1-infected patients with baseline viral load ≤ 100 000 copies/mL in the pooled ECHO and THRIVE phase 3, randomized, double-blind trials |
scientific article published on 28 August 2013 |
Statements
1 reference
Week 96 analysis of rilpivirine or efavirenz in HIV-1-infected patients with baseline viral load ≤ 100 000 copies/mL in the pooled ECHO and THRIVE phase 3, randomized, double-blind trials (English)
1 reference
J-M Molina
1 reference
N Clumeck
1 reference
C Orkin
1 reference
L T Rimsky
1 reference
S Vanveggel
1 reference
M Stevens
1 reference
ECHO and THRIVE Study Groups
1 reference
28 August 2013
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference